Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
63.6M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
28.2M
-
Shares change
-
+437K
-
Total reported value, excl. options
-
$620M
-
Value change
-
+$8.6M
-
Number of buys
-
49
-
Number of sells
-
-26
-
Price
-
$22.00
Significant Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q2 2019
94 filings reported holding RYTM - RHYTHM PHARMACEUTICALS, INC. - COM as of Q2 2019.
RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.2M shares
of 63.6M outstanding shares and own 44.32% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (4.91M shares), JANUS HENDERSON GROUP PLC (3.29M shares), BAKER BROS. ADVISORS LP (2.71M shares), TRV GP, LLC (1.98M shares), BlackRock Inc. (1.91M shares), RA CAPITAL MANAGEMENT, LLC (1.88M shares), FMR LLC (1.2M shares), VANGUARD GROUP INC (1.19M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.07M shares), and FEDERATED INVESTORS INC /PA/ (892K shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.